Skip to main content

Advertisement

Log in

Ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats

  • Experimental Research - Brain Injury
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Previous studies have demonstrated the neuroprotective effects of ethyl pyruvate in central nervous system (CNS) diseases. However, whether ethyl pyruvate attenuates early brain injury after subarachnoid hemorrhage (SAH) remains unknown. This study was conducted to investigate the potential effects of ethyl pyruvate on early brain injury induced by SAH and explore the underlying mechanisms.

Methods

Eighty-eight male Sprague-Dawley rats were used. An SAH model was induced by endovascular perforation. Ethyl pyruvate (100 mg/kg) or a vehicle was administered intraperitoneally at 1 h after SAH induction. SAH grade, neurological scores, brain water content, Evans blue extravasation, Western blots, and immunofluorescence were used to study the mechanisms of ethyl pyruvate.

Results

Ethyl pyruvate treatment inhibited microglia activation and reduced the expression of proinflammatory cytokines (IL-1β and TNF-α). Ethyl pyruvate treatment also prevented disruption of tight junction proteins (occluding and claudin-5) and reduced expression of MMP-9. In addition, ethyl pyruvate treatment markedly reduced TUNEL-positive cells and expression of cleaved caspase-3.

Conclusions

Our results indicated that ethyl pyruvate treatment attenuated early brain injury and improved neurological function after SAH by inhibiting microglia activation and apoptosis and stabilizing the BBB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724–7732

    CAS  PubMed  Google Scholar 

  2. Aslani F, Schuppe HC, Guazzone VA, Bhushan S, Wahle E, Lochnit G, Lustig L, Meinhardt A, Fijak M (2015) Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis. Hum Reprod 30:417–431

    Article  PubMed  Google Scholar 

  3. Bauer AT, Burgers HF, Rabie T, Marti HH (2010) Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30:837–848

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cahill J, Calvert JW, Zhang JH (2006) Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:1341–1353

    Article  CAS  PubMed  Google Scholar 

  5. Chen D, Wei XT, Guan JH, Yuan JW, Peng YT, Song L, Liu YH (2012) Inhibition of c-Jun N-terminal kinase prevents blood–brain barrier disruption and normalizes the expression of tight junction proteins clautin-5 and ZO-1 in a rat model of subarachnoid hemorrhage. Acta Neurochir (Wien) 154:1469–1476, discussion 1476

    Article  Google Scholar 

  6. Chen J, Chen G, Li J, Qian C, Mo H, Gu C, Yan F, Yan W, Wang L (2014) Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: a possible role for the regulation of pro-inflammatory cytokines. J Pineal Res 57:340–347

    Article  CAS  PubMed  Google Scholar 

  7. Chen J, Wang L, Wu C, Hu Q, Gu C, Yan F, Li J, Yan W, Chen G (2014) Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J Pineal Res 56:12–19

    Article  CAS  PubMed  Google Scholar 

  8. Chen S, Feng H, Sherchan P, Klebe D, Zhao G, Sun X, Zhang J, Tang J, Zhang JH (2014) Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol 115C:64–91

    Article  Google Scholar 

  9. Chen Y, Zhang Y, Tang J, Liu F, Hu Q, Luo C, Feng H, Zhang JH (2015) Norrin protected blood–brain barrier via frizzled-4/beta-catenin pathway after subarachnoid hemorrhage in rats. Stroke 46:529–536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Cho IH, Kim SW, Kim JB, Kim TK, Lee KW, Han PL, Lee JK (2006) Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Neurosci Res 84:1505–1511

    Article  CAS  PubMed  Google Scholar 

  11. Choi DK, Leem JG, Shin JW, Suh JH (2012) Effects of ethyl pyruvate on allodynia, TNF-alpha expression, and apoptosis in the dorsal root ganglion after spinal nerve ligation injury. Korean J Pain 25:213–220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fujii M, Sherchan P, Soejima Y, Hasegawa Y, Flores J, Doycheva D, Zhang JH (2014) Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. Exp Neurol 261:396–403

    Article  CAS  PubMed  Google Scholar 

  13. Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH (2013) Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4:432–446

    Article  PubMed  PubMed Central  Google Scholar 

  14. Garcia JH, Wagner S, Liu KF, Hu XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation Stroke 26:627–634, discussion 635

    CAS  PubMed  Google Scholar 

  15. Greenhalgh AD, Brough D, Robinson EM, Girard S, Rothwell NJ, Allan SM (2012) Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech 5:823–833

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Guo J, Zhang J, Luo X, Luo W, Lin C, Zhang K, Ji Y (2014) Effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion. Exp Ther Med 7:1197–1202

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Hasegawa Y, Suzuki H, Sozen T, Altay O, Zhang JH (2011) Apoptotic mechanisms for neuronal cells in early brain injury after subarachnoid hemorrhage. Acta Neurochir Suppl 110:43–48

    PubMed  Google Scholar 

  18. Jang M, Lee MJ, Cho IH (2014) Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms. Brain Behav Immun 38:151–165

    Article  CAS  PubMed  Google Scholar 

  19. Kim HS, Cho IH, Kim JE, Shin YJ, Jeon JH, Kim Y, Yang YM, Lee KH, Lee JW, Lee WJ, Ye SK, Chung MH (2008) Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. Free Radic Biol Med 45:950–963

    Article  CAS  PubMed  Google Scholar 

  20. Kim JB, Yu YM, Kim SW, Lee JK (2005) Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 1060:188–192

    Article  CAS  PubMed  Google Scholar 

  21. Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, Kotulska K, Olakowska E, Marcol W, Liskiewicz A, Jedrzejowska-Szypulka H (2012) Interleukin-1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr Neurovasc Res 9:159–166

    Article  CAS  PubMed  Google Scholar 

  22. Li Z, Liang G, Ma T, Li J, Wang P, Liu L, Yu B, Liu Y, Xue Y (2015) Blood–brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage. Metab Brain Dis 30:597–603

    Article  CAS  PubMed  Google Scholar 

  23. Macdonald RL (2014) Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10:44–58

    Article  CAS  PubMed  Google Scholar 

  24. Nag S, Kapadia A, Stewart DJ (2011) Review: molecular pathogenesis of blood–brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 37:3–23

    Article  CAS  PubMed  Google Scholar 

  25. Ostrowski RP, Colohan AR, Zhang JH (2006) Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28:399–414

    Article  CAS  PubMed  Google Scholar 

  26. Pulathan Z, Altun G, Hemsinli D, Mentese A, Yulug E, Civelek A (2014) Role of ethyl pyruvate in systemic inflammatory response and lung injury in an experimental model of ruptured abdominal aortic aneurysm. Biomed Res Int 2014:857109

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sehba FA, Hou J, Pluta RM, Zhang JH (2012) The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97:14–37

    Article  PubMed  PubMed Central  Google Scholar 

  28. Sehba FA, Mostafa G, Knopman J, Friedrich V, Bederson JB (2004) Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 101:633–640

    Article  PubMed  Google Scholar 

  29. Shi H, Wang HL, Pu HJ, Shi YJ, Zhang J, Zhang WT, Wang GH, Hu XM, Leak RK, Chen J, Gao YQ (2015) Ethyl Pyruvate Protects against Blood–brain Barrier Damage and Improves Long-term Neurological Outcomes in a Rat Model of Traumatic Brain Injury. CNS Neurosci Ther 21:374–384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Shin JH, Lee HK, Lee HB, Jin Y, Lee JK (2014) Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain. Neurosci Lett 558:159–163

    Article  CAS  PubMed  Google Scholar 

  31. Su X, Wang H, Zhu L, Zhao J, Pan H, Ji X (2013) Ethyl pyruvate ameliorates intracerebral hemorrhage-induced brain injury through anti-cell death and anti-inflammatory mechanisms. Neuroscience 245:99–108

    Article  CAS  PubMed  Google Scholar 

  32. Sugawara T, Ayer R, Jadhav V, Zhang JH (2008) A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167:327–334

    Article  PubMed  PubMed Central  Google Scholar 

  33. Yan F, Hu Q, Chen J, Wu C, Gu C, Chen G (2013) Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett 543:163–167

    Article  CAS  PubMed  Google Scholar 

  34. Yuksel S, Tosun YB, Cahill J, Solaroglu I (2012) Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis. Turk Neurosurg 22:529–533

    PubMed  Google Scholar 

  35. Zhan Y, Krafft PR, Lekic T, Ma Q, Souvenir R, Zhang JH, Tang J (2015) Imatinib preserves blood–brain barrier integrity following experimental subarachnoid hemorrhage in rats. J Neurosci Res 93:94–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mei Zhang.

Ethics declarations

All experimental procedures for rats were approved by the Institutional Animal Care and Use Committee of Hangzhou Normal University and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest the subject matter or materials discussed in this manuscript.

Funding

No funding was received for this research.

Additional information

Comment

This study has the merit of focusing the research on aneurysmal subarachnoid hemorrhage (aSAH) on mechanisms of brain dysfunction that are different from cerebral vasospasm. Although cerebral vasospasm is still considered the principal cause of delayed neurological deterioration after aSAH, there is increasing scientific evidence that other pathogenetic mechanisms may play a role in determining delayed ischemia (1). Cerebral vasospasm and delayed ischemia could represent separate clinical entities both occurring in aSAH patients, but with different pathophysiologies and different relevance to the outcome. There are many hints confirming this hypothesis. Probably, the most evident is the fact that vasospasm is observed in most patients who suffer from aSAH, while only 20–30 % of them develop clinical symptoms. Another unequivocal piece of evidence showing that radiographic vasospasm and clinical outcome are not directly associated is the greater incidence of radiographic vasospasm in patients who undergo clipping as compared to those who receive endovascular treatment, but with similar results of the two techniques in terms of morbidity and mortality. These circumstances are widely recognized; nonetheless, they remain oddities that cannot be convincingly explained if we consider cerebral vasospasm as the only cause of delayed cerebral ischemia. Here the authors found that ethyl pyruvate alleviated behavioral dysfunction in experimental animals by inhibiting neural cell apoptosis and stabilizing the blood-brain barrier. These mechanisms, together with vasospasm, hypercoagulation, apoptosis, oxidative stress, cortical spreading depolarization, and inflammation, deserve further analysis concerning their role in the pathophysiology of neurological worsening after aSAH.

1. Tomasello F, Conti A (2015) The pathogenetic mechanism of delayed ischemic deficit in aneurysmal subarachnoid hemorrhage: a still-unsolved issue. World Neurosurg 84: 1207–1208.

Alfredo Conti

Messina, Italy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fang, R., Zheng, X. & Zhang, M. Ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats. Acta Neurochir 158, 1069–1076 (2016). https://doi.org/10.1007/s00701-016-2795-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-016-2795-3

Keywords

Navigation